INTRODUCTION
Na+,K+-ATPase couples the transport of monovalent cations across the plasma membrane with the hydrolysis of ATP. During the catalytic cycle, three sodium ions are pumped out of the cell for every two potassium ions transported into the cell (reviewed in [1, 2] binding under Mg2+-P, conditions. These monovalent cation effects have previously been described in reference to purified Na+,K+-ATPase and are hypothesized to report functionally important conformational alterations of the enzyme (reviewed in [3] ).
The amino acids of the Na+,K+-ATPase involved in binding efficients of 2 for both wild-type sheep al (K, = 0.743 + 0.044 mM) and E327A (K, = 0.875 + 0.067 mM). At concentrations of K+ above 10 mM, the sheep al competition curve levelled off whereas the inhibition curve for E327A displayed a stimulation in ouabain binding. This stimulation in [3H]ouabain binding also occurred with Rb+, Cs+ and Li+, but was never observed with choline or Na+, suggesting that this effect was not due to ionic strength. From these [3H]ouabain-binding studies, it is obvious that the mutant enzyme E327A in the presence of Mg2+, Pi and ouabain, interacts with monovalent cations in a unique fashion. One interpretation of these data is that the glutamic acid residue at position 327 is involved in a conformational transition induced by the binding of monovalent cations to the Na+,K+-ATPase and that this transition is inhibited by the mutation of E327A. and translocating cations have not yet been identified. One theory suggests that negatively charged residues within the membrane are important as neutralizing groups to carry the cations across the lipid bilayer. Thus, these transmembrane, anionic residues have been targets in chemical modification and site-directed mutagenesis studies.
Chemical labelling experiments performed with the hydrophobic, carboxyl-specific reagent, dicyclohexylcarbodiimide, have implicated two glutamic acid residues within the transmembrane domains which may be involved in neutralizing and transporting monovalent cations [4] . These residues are positioned at 327 and 955 in the amino acid sequence of the sheep al isoform. Site-directed mutagenesis, expression and kinetic characterization of modifications made at positions E955 and E956 showed that these mutant enzymes have no marked reduction in their cation dependence of ATPase activity [5] . In contrast, when E327 was altered either to a leucine or a glutamine residue, a decrease in both the apparent sodium-dependence and potassium-dependence of ATPase activity was observed [6] . These mutagenesis studies involved the expression of a ouabainresistant form of Na+,K+-ATPase (rat a2* isoforms) in cells which possess an ouabain-sensitive endogenous protein (e.g. HeLa cells) and growing these transfected cells in the presence of the drug. This selection scheme is limited in that if the cells do not possess an active ouabain-resistant enzyme, the cells do not survive the ouabain selection. Hence, any mutation rendering the expressed enzyme severely impaired will result in no stable cell lines. This was the case when E327 was altered to alanine [7] .
Abbreviations used: E327A, a mutant sheep a.l isoform of Na+,K+-ATPase in which the glutamic acid at position 327 is altered to an alanine residue; rat a2*, a mutant rat isoform of Na+,K+-ATPase in which the following changes have been introduced to make the protein ouabain-resistant: L11 R and N122D; G418, geneticin (a neomycin analogue); SR, sarcoplasmic reticulum; AC50, concentration producing half-maximal activation.
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Although these original site-directed mutagenesis studies revealed that E327 was extremely important in the catalytic turnover of Na+,K+-ATPase, only functional, ouabain-resistant mutant proteins can be analysed by ATPase activity measurements.
Our objective in this study was to establish an expression and assay system by which functionally impaired enzymes could be probed to identify which step in the catalytic cycle was affected by the mutated site. The expression system we utilized had previously been developed to study mutations which might alter the affinity of Na+,K+-ATPase for ouabain [8] . This system involved construction of the functionally impaired mutation in the ouabain-sensitive sheep acl cDNA and co-transfecting this mutant cDNA along with a neomycin-resistance gene into a ouabain-resistant cell line (NIH 3T3 mouse cell line). Thus 
EXPERIMENTAL Materials
[3H]Ouabain was purchased from DuPont-New England Nuclear and ouabain was from Calbiochem or Sigma. The specific radioactivity of [3H]ouabain was determined as previously described [9] and was calculated to be 1.69 x 10-5 pmol/d.p.m. Cell culture supplies were purchased from Gibco, Life Technologies, Inc. and Fisher. All other reagents (NaCl, KCI, Tris base, HCI, phosphoric acid, MgCl2) were from Fisher. NIH 3T3 cell clones and tissue culture G418-resistant cell lines expressing the wild-type sheep al cDNA and cDNA encoding the sheep a.l mutant E327A were established using the procedure previously described [8] . These cell lines were maintained in Dulbecco's modified Eagle's medium containing 10 % calf serum and 400 1g/ml G418 [10] .
Isolatlon of crude plasma membranes from NIH 3T3 cells Crude membranes were isolated from transfected NIH 3T3 cells as previously described [8] . The crude membranes were treated with Nal for further purification [11] .
Western-blot analysis In this model, E is the enzyme, 0 is ouabain, KD is the binding constant for ouabain, K1 is the binding constant for each K+ ion, and a is the interaction factor per K+ ion (that is, one K+ ion increases the binding constant for ouabain from KD to aK, and the second K' ion increases ouabain's binding constant to a2KD). Thus, for an a value of 10, the KD for ouabain will be increased by a factor of 100 at saturating K+. shown on the x-axis. The
It is obvious from the data shown in Figure 5 Figure 7 ). This could represent a non-specific effect due to high ionic strength (see next paragraph). Whatever the cause, this decrease in binding severely limits the extent to which the activation phase can be reliably modelled. Increasing the number of data points would in theory increase the precision of the model in this region, but this will be limited by the magnitude of the activation portion of the curve. As noted above there is a potential problem with ionic strength effects at high concentrations of cations. This is clearly not the explanation for the 'dip' in the mutant curve since this occurs at about 10 mM K+ whereas this concentration of Na+ has almost no effect. However, the inhibition with K+ that occurs above 150 mM could be due to non-specific effects since choline chloride also inhibits ouabain binding at high concentrations (Figure 6) [14] . If this were the case with choline, then it is also possible that the inhibition seen with high concentrations of K+ ( > 150 mM) might also be due to a Na+-like effect.
Effects of other monovalent catlons
In view of the clear distinction between the inhibition curves for K+ and Na+ on the E327A membranes, it was of interest to examine other cations. Figure 7 shows (4) 2.10+0.12 (n = 3). The activation phase had Ka = 21.0+3.5mM, ,B= 1.52+0.09. As with K' and choline, concentrations of Rb+ > 150 mM exert an additional inhibition of binding in the E327A preparation. Thus, the initial inhibition phase for both K+ and Rb+ on wild type and E327A had a K1 of about 1 mM. The interaction factor a was lower for Rb+ than for K+, suggesting that each Rb+ bound reduced the affinity of the enzyme for ouabain to a lesser extent than each K+ bound.
Cs+ and Li+ were also examined as inhibitors of ouabain binding (data not shown). The mutant E327A displayed a triphasic Cs+ or Li+-induced inhibition-activation-inhibition pattern qualitatively similar to that observed for K+ and Rb+. The magnitude of the initial inhibition phase induced by Cs+ and Li+ was less pronounced compared with K+ and Rb+. Inhibition constants could not be determined due to an inability to adequately resolve the individual phases.
DISCUSSION
The mutation E327A is one of several mutations introduced into the Na+,K+-ATPase which renders the pump functionally impaired when tested as previously described [7] . In the present study we showed that when this mutation was incorporated into a sheep al cDNA and expressed in 3T3 cells, [3H]ouabain binding was easily detected. It is clear from the results shown in Figure 2 that under Mg-P1 conditions in the absence of monovalent cations, the wild-type and mutant enzymes bind [3H]ouabain with virtually identical affinities. The KD of ouabain for the wild-type protein (1.53 nM) determined here by equilibrium competition binding assays agrees well with the value previously determined by on and off rate measurements (1.55 nM; [8] Alternatively, K+ and choline might interact with a specific binding site to produce this inhibition. In any event, it is obvious from the lack ofeffect ofcholine chloride in the low concentration range (1-100 mM) that the initial inhibition and activation in the K+ curve is not due to ionic strength effects.
The initial inhibition phase of the K+ competition curves for both the wild-type sheep al and the mutant E327A suggests that two K+ ions bind to the enzyme with affinities similar to those calculated to stimulate ATPase activity (1.03 + 0.22 mM; [6] The detailed mechanism of Na+/K+ transport by the Na+,K+-ATPase is not known but is thought to involve the binding of the cations to their site(s) followed by one or more conformational changes in the protein which carry the cations to the opposite side of the cell membrane. The E327A mutant form of the enzyme cannot support cell viability [7] , indicating a major defect in its ability to transport Na+ and K+. The K+ inhibition curves reported here suggest the exposure of a third K+ site in the E327A mutant which can only be explained through altered conformational characteristics of the ATPase. The Na+ inhibition curves indicate that two Na+ ions interact with the mutant promoting a conformational change which reduces the affinity of the enzyme for ouabain. These Na+ competition data suggest two possible functions for the altered glutamic acid; either the residue lies within the Na+-binding pocket or the residue is important conformationally in differentiating between a Na+-complexed form of the enzyme and an uncomplexed form. The common role for the glutamic acid at position 327 in the sheep al isoform, suggested by both the K+ and the Na+ inhibition data, is that this residue plays a pivotal function in the cascade of conformational changes normally induced by the binding of monovalent cations. Altering the glutamic acid hinders conformational changes from occurring in the protein such that ATPase activity is not sufficient to produce the ionic gradient essential for cell viability.
This glutamic acid residue is conserved between the amino acid sequences of the SR Ca2+-ATPase and the Na+,K+-ATPase. Extensive site-directed mutagenesis studies have been done on this site (E309) in the Ca2+-ATPase [17] [18] [19] . When the mutant E309A of Ca2+-ATPase was expressed transiently in COS cells, this mutant was deficient in both its ability to transport Ca2+ and in ATPase activity. These findings are in agreement with the inability ofthis mutant in Na+,K+-ATPase to support cell viability in the presence of ouabain [7] . Vilsen 
